Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
04 Oct 2019
Historique:
received: 14 09 2019
revised: 02 10 2019
accepted: 03 10 2019
entrez: 9 10 2019
pubmed: 9 10 2019
medline: 11 2 2020
Statut: epublish

Résumé

Carbonic anhydrases (CAs, EC 4.2.1.1) catalyze the fundamental reaction of CO

Identifiants

pubmed: 31590289
pii: molecules24193580
doi: 10.3390/molecules24193580
pmc: PMC6804193
pii:
doi:

Substances chimiques

Antigens, Neoplasm 0
Carbonic Anhydrase Inhibitors 0
Coumarins 0
CA9 protein, human EC 4.2.1.1
Carbonic Anhydrase IX EC 4.2.1.1
Carbonic Anhydrases EC 4.2.1.1
carbonic anhydrase XII EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Chem Biol Interact. 2014 Jul 25;218:42-9
pubmed: 24812029
ACS Med Chem Lett. 2018 Jun 06;9(7):725-729
pubmed: 30034608
Chemistry. 2018 Jun 4;24(31):7840-7844
pubmed: 29603439
ScientificWorldJournal. 2014;2014:189824
pubmed: 25610898
Bioorg Med Chem Lett. 2010 Nov 15;20(22):6504-7
pubmed: 20932744
Bioorg Med Chem. 2012 Feb 15;20(4):1584-93
pubmed: 22264758
Bioorg Med Chem. 2012 Feb 1;20(3):1175-80
pubmed: 22257528
J Med Chem. 2018 Dec 13;61(23):10860-10874
pubmed: 30433782
Br J Pharmacol. 2014 Dec;171(23):5252-64
pubmed: 25039358
Biol Pharm Bull. 2014;37(1):60-6
pubmed: 24389482
Int J Mol Sci. 2011;12(9):5747-61
pubmed: 22016624
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9545-50
pubmed: 11493685
Bioorg Med Chem Lett. 2015 Feb 1;25(3):508-13
pubmed: 25542589
Biochem Pharmacol. 2009 Jun 15;77(12):1773-9
pubmed: 19428332
Expert Opin Drug Discov. 2019 Nov;14(11):1175-1197
pubmed: 31436118
Bioorg Med Chem. 2010 May 15;18(10):3371-8
pubmed: 20435480
Bioorg Med Chem Lett. 2010 Aug 1;20(15):4511-4
pubmed: 20580555
Phytomedicine. 2014 Jul-Aug;21(8-9):1037-42
pubmed: 24837471
Bioorg Med Chem Lett. 2011 Nov 1;21(21):6420-5
pubmed: 21920747
Eur J Med Chem. 2013 Jun;64:540-53
pubmed: 23685572
J Enzyme Inhib Med Chem. 2016 Dec;31(6):1198-202
pubmed: 26586254
Commun Agric Appl Biol Sci. 2007;72(4):785-93
pubmed: 18396811
J Enzyme Inhib Med Chem. 2004 Aug;19(4):373-9
pubmed: 15558956
Bioorg Med Chem Lett. 2010 Dec 15;20(24):7255-8
pubmed: 21067924
PLoS One. 2016 Oct 21;11(10):e0164585
pubmed: 27768694
Bioorg Chem. 2012 Feb;40(1):131-6
pubmed: 22130072
J Biol Chem. 1971 Apr 25;246(8):2561-73
pubmed: 4994926
J Enzyme Inhib Med Chem. 2013 Apr;28(2):397-401
pubmed: 22299576
Biochemistry. 2016 Aug 23;55(33):4642-53
pubmed: 27439028
Eur J Med Chem. 2015 Nov 13;105:171-81
pubmed: 26491980
Chemistry. 2019 Jan 24;25(5):1188-1192
pubmed: 30411821
J Enzyme Inhib Med Chem. 2012 Dec;27(6):759-72
pubmed: 22468747
Expert Opin Drug Discov. 2017 Jan;12(1):61-88
pubmed: 27783541
J Am Chem Soc. 2009 Mar 4;131(8):3057-62
pubmed: 19206230
Bioorg Med Chem. 2017 May 1;25(9):2577-2582
pubmed: 28343756
J Enzyme Inhib Med Chem. 2016;31(3):345-60
pubmed: 26619898
Int Immunopharmacol. 2012 Oct;14(2):145-9
pubmed: 22771447

Auteurs

Victor Kartsev (V)

InterBioscreen, 119019 Moscow, Russia. vkartsev@ibscreen.chg.ru.

Athina Geronikaki (A)

School of Health, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. geronikaki@gmail.com.

Silvia Bua (S)

Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche e Nutraceutiche, Universita' Degli Studi Di Firenze, Sesto Fiorentino, 50019 Florence, Italy. silvia.bua@unifi.it.

Alessio Nocentini (A)

Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche e Nutraceutiche, Universita' Degli Studi Di Firenze, Sesto Fiorentino, 50019 Florence, Italy. alessio.nocentini@unifi.it.

Anthi Petrou (A)

School of Health, Department of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece. anthi.petrou.thessaloniki1@gmail.com.

Boris Lichitsky (B)

Zelinsky Institute of Organic Chemistry, Leninsky prospect, 119991, Moscow, Russia. blich2006@mail.ru.

Mykhaylo Frasinyuk (M)

Institute of Bioorganic Chemistry and Petrochemistry, National Academy of Science of Ukraine, 02094 Kiev, Ukraine. mykhaylo.frasinyuk@ukr.net.

Janis Leitans (J)

Latvian Biomedical Research and Study Center, Ratsupites 1, LV-1067 Riga, Latvia. janis.leitans@biomed.lu.lv.

Andris Kazaks (A)

Latvian Biomedical Research and Study Center, Ratsupites 1, LV-1067 Riga, Latvia. andris@biomed.lu.lv.

Kaspars Tars (K)

Latvian Biomedical Research and Study Center, Ratsupites 1, LV-1067 Riga, Latvia. kaspars@biomed.lu.lv.

Claudiu T Supuran (CT)

Dipartimento Neurofarba, Sezione Di Scienze Farmaceutiche e Nutraceutiche, Universita' Degli Studi Di Firenze, Sesto Fiorentino, 50019 Florence, Italy. claudiu.supuran@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH